8-KOther EventsExhibits & Filings

PFIZER INC 8-K Report, Corporate Update (May 16, 2007)

Filed May 16, 2007For Securities:PFE

Summary

This 8-K filing from Pfizer Inc. on May 16, 2007, serves primarily to furnish financial data in XBRL format as part of the SEC's pilot program. The XBRL-formatted documents are derived from Pfizer's previously filed Q1 2007 10-Q report (filed May 4, 2007) and include condensed consolidated statements of income, balance sheets, and cash flows for relevant periods. Investors are strongly cautioned that this information is unaudited and should not be relied upon for investment decisions. They should continue to refer to the official, audited financial statements as filed with the SEC. The purpose of this filing is purely for testing the XBRL technology and format. As such, the data presented here is not considered 'filed' for liability purposes under the Exchange Act and will not be incorporated into other SEC filings unless expressly stated. This 8-K is a procedural step to support regulatory technology initiatives rather than to report new material events or financial performance.

Key Highlights

  • 1Pfizer is participating in the SEC's voluntary XBRL pilot program.
  • 2The filing includes XBRL-formatted financial data from Pfizer's Q1 2007 10-Q report.
  • 3Data covers condensed consolidated statements of income, balance sheets, and cash flows for specified periods.
  • 4Crucially, the XBRL financial data is unaudited and not the official financial statements.
  • 5Investors are directed to rely on the official filed versions of Pfizer's financial statements.
  • 6Information in this 8-K, including the XBRL exhibits, is not deemed 'filed' for Section 18 liability.
  • 7This filing is for technological testing purposes, not for reporting new material events.

Frequently Asked Questions

The primary purpose of this 8-K filing is for Pfizer Inc. to participate in the SEC's voluntary XBRL pilot program. It provides financial data from its Q1 2007 10-Q report in XBRL format to test the new reporting technology and format.

No, investors should not rely on the financial information presented in this 8-K filing for making investment decisions. The filing explicitly states that the XBRL data is unaudited and is not the official financial statement. Investors should continue to refer to the official filings with the SEC.

The XBRL-formatted documents include the Condensed Consolidated Statements of Income for the three months ended April 1, 2007, and April 2, 2006; Condensed Consolidated Balance Sheets as of April 1, 2007, and December 31, 2006; and Condensed Consolidated Statements of Cash Flows for the three months ended April 1, 2007, and April 2, 2006.

No, the information in this 8-K, including the XBRL exhibits, is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities associated with Section 18 and will not be incorporated by reference into other SEC filings unless specifically noted.